Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
India
/
Pharmaceuticals & Biotech
Create a narrative
Indoco Remedies Community
NSEI:INDOCO Community
4
Narratives
written by author
0
Comments
on narratives written by author
13
Fair Values set
on narratives written by author
Create a narrative
Indoco Remedies
Popular
Undervalued
Overvalued
Community Investing Ideas
Indoco Remedies
TH
ThewealthyinvestorbyDSAB
Community Contributor
Indoco Remedies Will Benefit from India's Healthcare Growth
Indoco Remedies presents a compelling investment opportunity due to its balanced business model, focusing on both domestic strength and international expansion. The company is well-positioned to benefit from: India’s growing healthcare ecosystem , driven by higher spending, population growth, and rising disease burden.
View narrative
₹380.00
FV
15.3% undervalued
intrinsic discount
-6.53%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
6 months ago
author updated this narrative
Indoco Remedies
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Intensifying FDA Scrutiny And Competitive Pressures Will Erode Profitability
Key Takeaways Regulatory headwinds, undifferentiated generics, and capital-intensive OTC expansion combine to threaten profit margins, put cash flows at risk, and constrain long-term growth prospects. Elevated debt and shrinking revenue limit financial flexibility, raising concerns over sustainability, new investments, and the potential for ongoing margin pressure.
View narrative
₹200.00
FV
60.9% overvalued
intrinsic discount
14.37%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Indoco Remedies
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
Growing Global Healthcare Will Fuel Expanding Generics And OTC Markets
Key Takeaways Strategic investments in manufacturing, process automation, and plant rationalization could drive substantial revenue growth and margin improvement beyond consensus expectations, boosting group earnings power. Expansion into high-margin OTC oral care and strength in generics position Indoco for sustained domestic and global growth, leveraging long-term demographic and healthcare trends.
View narrative
₹325.00
FV
1.0% undervalued
intrinsic discount
15.51%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Indoco Remedies
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Plant Remediation And Clarity Pharma Partnership Will Support Future Market Expansion
Key Takeaways Resolving manufacturing plant issues is critical for increasing U.S. market supply, boosting revenue, and minimizing compliance risks. Strategic U.K. partnerships and refurbished supply chains in Europe are poised to drive significant international revenue growth.
View narrative
₹244.25
FV
31.8% overvalued
intrinsic discount
13.64%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
Updated
narrative
Your Valuation for
INDOCO
INDOCO
Indoco Remedies
Your Fair Value
₹
Current Price
₹321.80
66.4% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-737m
31b
2015
2018
2021
2024
2025
2027
2030
Revenue ₹30.7b
Earnings ₹4.4b
Advanced
Set Fair Value